208 related articles for article (PubMed ID: 33621598)
41. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
[TBL] [Abstract][Full Text] [Related]
42. Interstitial Lung Disease in India. Results of a Prospective Registry.
Singh S; Collins BF; Sharma BB; Joshi JM; Talwar D; Katiyar S; Singh N; Ho L; Samaria JK; Bhattacharya P; Gupta R; Chaudhari S; Singh T; Moond V; Pipavath S; Ahuja J; Chetambath R; Ghoshal AG; Jain NK; Devi HJ; Kant S; Koul P; Dhar R; Swarnakar R; Sharma SK; Roy DJ; Sarmah KR; Jankharia B; Schmidt R; Katiyar SK; Jindal A; Mangal DK; Singh V; Raghu G
Am J Respir Crit Care Med; 2017 Mar; 195(6):801-813. PubMed ID: 27684041
[TBL] [Abstract][Full Text] [Related]
43. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
44. [Overview of the interstitial lung disease in the Southeast of Mexico].
Martínez-Ponce JC; Mejía-Ávila M; Vázquez-López S; Pou-Aguilar YN; Ortiz-Farias DL; Cortes-Telles A
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):55-64. PubMed ID: 33667044
[TBL] [Abstract][Full Text] [Related]
45. Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study.
Bauer PR; Kalra S; Osborn TG; St Sauver J; Hanson AC; Schroeder DR; Ryu JH
Respir Med; 2015 Mar; 109(3):397-405. PubMed ID: 25670028
[TBL] [Abstract][Full Text] [Related]
46. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
[TBL] [Abstract][Full Text] [Related]
47. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
48. Questionnaires or Serum Immunoglobulin G Testing in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
Jenkins AR; Chua A; Chami H; Diaz-Mendoza J; Duggal A; Knight S; Patolia S; Tamae-Kakazu M; Raghu G; Wilson KC
Ann Am Thorac Soc; 2021 Jan; 18(1):130-147. PubMed ID: 32780584
[No Abstract] [Full Text] [Related]
49. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
50. [Diffuse interstitial lung disease of possible occupational origin treated at the Navarra Health Service. Navarra, Spain, 2017-2022].
García López V; Jové Gómez D; Marin Martinez B; Chocrón Miño S; Castillo Sabogal A; Ibarra García A
Arch Prev Riesgos Labor; 2024 Apr; 27(2):173-189. PubMed ID: 38655592
[TBL] [Abstract][Full Text] [Related]
51. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
[TBL] [Abstract][Full Text] [Related]
52. Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology.
Godbert B; Wissler MP; Vignaud JM
Eur Respir Rev; 2013 Jun; 22(128):117-23. PubMed ID: 23728865
[TBL] [Abstract][Full Text] [Related]
53. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
[TBL] [Abstract][Full Text] [Related]
54. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
[TBL] [Abstract][Full Text] [Related]
56. Mind the gaps: Occupational and environmental exposures in interstitial lung diseases.
Yates DH
Respirology; 2022 Aug; 27(8):569-570. PubMed ID: 35672270
[No Abstract] [Full Text] [Related]
57. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.
Assayag D; Adegunsoye A; Sheehy R; Morisset J; Khalil N; Johannson KA; Marcoux V; Kolb M; Fisher JH; Manganas H; Wrobel J; Wilsher M; De Boer S; Mackintosh J; Chambers DC; Glaspole I; Keir GJ; Lee CT; Jablonski R; Vij R; Strek ME; Corte TJ; Ryerson CJ
Chest; 2023 May; 163(5):1156-1165. PubMed ID: 36621759
[TBL] [Abstract][Full Text] [Related]
58. Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort.
Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Adelstein S; Webster S; Corte TJ
Respiration; 2021; 100(9):853-864. PubMed ID: 33873185
[TBL] [Abstract][Full Text] [Related]
59. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
[TBL] [Abstract][Full Text] [Related]
60. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.
Adegunsoye A; Oldham JM; Demchuk C; Montner S; Vij R; Strek ME
Respir Med; 2016 May; 114():53-60. PubMed ID: 27109811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
